- Home
- DLHC vs MGX Comparison
DLHC vs MGX Comparison
Compare DLHC & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- MGX
- Stock Information
- Founded
- DLHC 1969
- MGX 2018
- Country
- DLHC United States
- MGX United States
- Employees
- DLHC N/A
- MGX N/A
- Industry
- DLHC Business Services
- MGX
- Sector
- DLHC Consumer Discretionary
- MGX
- Exchange
- DLHC Nasdaq
- MGX NYSE
- Market Cap
- DLHC 112.9M
- MGX 100.7M
- IPO Year
- DLHC N/A
- MGX 2024
- Fundamental
- Price
- DLHC $7.37
- MGX $2.55
- Analyst Decision
- DLHC
- MGX Strong Buy
- Analyst Count
- DLHC 0
- MGX 7
- Target Price
- DLHC N/A
- MGX $16.67
- AVG Volume (30 Days)
- DLHC 27.1K
- MGX 1.8M
- Earning Date
- DLHC 02-05-2025
- MGX 02-12-2025
- Dividend Yield
- DLHC N/A
- MGX N/A
- EPS Growth
- DLHC 410.00
- MGX N/A
- EPS
- DLHC 0.51
- MGX N/A
- Revenue
- DLHC $395,937,000.00
- MGX $55,080,000.00
- Revenue This Year
- DLHC N/A
- MGX $16.91
- Revenue Next Year
- DLHC N/A
- MGX N/A
- P/E Ratio
- DLHC $14.43
- MGX N/A
- Revenue Growth
- DLHC 5.34
- MGX 45.13
- 52 Week Low
- DLHC $7.34
- MGX $1.61
- 52 Week High
- DLHC $17.58
- MGX $12.74
- Technical
- Relative Strength Index (RSI)
- DLHC 39.40
- MGX 39.73
- Support Level
- DLHC $7.48
- MGX $2.57
- Resistance Level
- DLHC $7.60
- MGX $2.95
- Average True Range (ATR)
- DLHC 0.23
- MGX 0.29
- MACD
- DLHC -0.04
- MGX -0.05
- Stochastic Oscillator
- DLHC 3.30
- MGX 4.91
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).